...
首页> 外文期刊>Revista Brasileira de Cirurgia Cardiovascular >Cardioplegia using low volumic cardioplegic agents: morphological study in isolated rabbit hearts
【24h】

Cardioplegia using low volumic cardioplegic agents: morphological study in isolated rabbit hearts

机译:使用低容量心脏停搏药进行心脏停搏:离体兔心脏的形态学研究

获取原文

摘要

INTRODUCTION: Pharmacological cardioplegic solution aims to eliminate the consequences of ischemic damage, which results from the misbalance between the offer and consumption of energy during the arrest of the heart beats during cardiac surgery with cardiopulmonary bypass. OBJECTIVES: This research experimentally evaluates the structural and ultrastructural changes in isolated rabbit hearts submitted to arrest protected by a Low Volumetric Cardioplegic Solution (LVCS). MATERIAL AND METHOD: The study counted with a control group and two experimental groups. In group I the cardiac arrest was obtained by infusion of the LVCS for 2 hours. In group II the experiment was conducted in the same way until the arrest protected by LVCS for 2 hours, and immediately after reperfusion was performed with the Ringer Locke (RL) oxygenated solution for 1 hour. In the control group the hearts were perfused with the RL oxygenated solution for 2 hours. After the experiments, 8 samples of the left ventricle were fixed in 10% formaldehyde and 2.5% glutaraldehyde for histological and ultrastructural analysis. RESULTS: The myocardial cells, the fibroblasts and the endothelial cells which were observed in the experimental groups I and II, presented with marginalization of the heterochromatin, compaction of the nucleolus, change in the morphology of the mitochondria and compaction of the cristae. Also there was an increase of the density of the mitochondrial matrix. This indicates that the nuclear structure as well as the structure of the cytoplasmic organelles were altered when compared to the cells of the control group. CONCLUSION: The structural modifications were due a physiological adaptation of the cell, and not an indication of oncosis or apoptosis, suggesting that the cardioplegic solution used was efficient for the preservation of the cells.
机译:简介:药理性心脏停搏解决方案旨在消除缺血性损害的后果,这种损害是由于在进行心肺旁路手术的心脏手术中,在心跳停止期间能量供应和能量消耗之间的失衡造成的。目的:本研究通过实验评估了接受低容量心脏停搏液(LVCS)保护的孤立兔心脏的结构和超微结构变化。材料与方法:研究计数为对照组和两个实验组。在第一组中,通过输注LVCS 2小时获得心脏骤停。在第二组中,以相同的方式进行实验,直到被LVCS保护的逮捕持续2小时,然后在使用林格洛克(RL)含氧溶液进行再灌注后立即进行1小时。在对照组中,用RL含氧溶液灌注心脏2小时。实验后,将8个左心室样品固定在10%甲醛和2.5%戊二醛中,以进行组织学和超微结构分析。结果:实验组I和II中观察到的心肌细胞,成纤维细胞和内皮细胞呈现出异染色质边缘化,核仁紧实,线粒体形态变化和cr紧实。线粒体基质的密度也增加了。这表明与对照组的细胞相比,其核结构以及细胞质细胞器的结构均发生了改变。结论:结构修饰是由于细胞的生理适应性所致,而不是肿瘤或凋亡的迹象,这表明所用的心脏停搏液可以有效地保存细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号